Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Hydrocodone
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Side effects== [[File:Main symptoms of Hydrocodone overdose.svg|thumb|Main symptoms of Hydrocodone overdose]] Common [[adverse drug reaction|side effects]] of hydrocodone are [[nausea]], [[vomiting]], [[constipation]], [[drowsiness]], [[dizziness]], [[lightheadedness]], [[anxiety (mood)|anxiety]], abnormally happy or sad mood, dry throat, difficulty [[urination|urinating]], [[rash]], [[itching]], and contraction of the pupils. Serious side effects include slowed or irregular breathing and chest tightness.<ref name="MedlinePlus">{{cite web | url = https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601006.html | work = MedlinePlus | title = Hydrocodone Combination Products | publisher = U.S. National Library of Medicine | date = 1 October 2008 | access-date = 20 April 2013 | archive-date = 5 July 2016 | archive-url = https://web.archive.org/web/20160705111552/https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601006.html | url-status = live }}</ref> Several cases of progressive bilateral hearing loss unresponsive to steroid therapy have been described as an infrequent adverse reaction to hydrocodone/paracetamol misuse. This adverse effect has been considered by some to be due to the [[ototoxicity]] of hydrocodone.<ref name="pmid10733182">{{cite journal | vauthors = Friedman RA, House JW, Luxford WM, Gherini S, Mills D | title = Profound hearing loss associated with hydrocodone/acetaminophen abuse | journal = The American Journal of Otology | volume = 21 | issue = 2 | pages = 188–191 | date = March 2000 | pmid = 10733182 | doi = 10.1016/S0196-0709(00)80007-1 }}</ref><ref name="pmid17525781">{{cite journal | vauthors = Ho T, Vrabec JT, Burton AW | title = Hydrocodone use and sensorineural hearing loss | journal = Pain Physician | volume = 10 | issue = 3 | pages = 467–472 | date = May 2007 | pmid = 17525781 | url = http://www.painphysicianjournal.com/linkout_vw.php?issn=1533-3159&vol=10&page=467 | url-status = dead | archive-url = https://web.archive.org/web/20110723082234/http://www.painphysicianjournal.com/linkout_vw.php?issn=1533-3159&vol=10&page=467 | archive-date = 23 July 2011 }}</ref> Other researchers have suggested that paracetamol is the primary agent responsible for the ototoxicity.<ref name="pmid20493351">{{cite journal | vauthors = Yorgason JG, Kalinec GM, Luxford WM, Warren FM, Kalinec F | title = Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse: evidence from two parallel in vitro mouse models | journal = Otolaryngology–Head and Neck Surgery | volume = 142 | issue = 6 | pages = 814–9, 819.e1–2 | date = June 2010 | pmid = 20493351 | doi = 10.1016/j.otohns.2010.01.010 | s2cid = 25083914 }}</ref><ref name="pmid20193831">{{cite journal | vauthors = Curhan SG, Eavey R, Shargorodsky J, Curhan GC | title = Analgesic use and the risk of hearing loss in men | journal = The American Journal of Medicine | volume = 123 | issue = 3 | pages = 231–237 | date = March 2010 | pmid = 20193831 | pmc = 2831770 | doi = 10.1016/j.amjmed.2009.08.006 }}</ref> The U.S. [[Food and Drug Administration]] (FDA) assigns the drug to [[pregnancy category]] C, meaning that no adequate and well-controlled studies in humans have been conducted. A newborn of a mother taking opioid medications regularly prior to the birth will be physically dependent.<ref>{{Cite web|title=Neonatal abstinence syndrome: MedlinePlus Medical Encyclopedia|url=https://medlineplus.gov/ency/article/007313.htm|access-date=11 January 2022|website=medlineplus.gov|language=en|archive-date=28 July 2017|archive-url=https://web.archive.org/web/20170728061943/https://medlineplus.gov/ency/article/007313.htm|url-status=live}}</ref><ref>{{Cite web|title=Opioid Use and Opioid Use Disorder in Pregnancy|url=https://www.acog.org/en/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy|access-date=11 January 2022|website=www.acog.org|language=en|archive-date=11 January 2022|archive-url=https://web.archive.org/web/20220111225403/https://www.acog.org/en/clinical/clinical-guidance/committee-opinion/articles/2017/08/opioid-use-and-opioid-use-disorder-in-pregnancy|url-status=live}}</ref> The baby may also exhibit respiratory depression if the opioid dose was high.<ref name="DailyMed-Reprexain" /> An epidemiological study indicated that opioid treatment during early pregnancy results in increased risk of various birth defects.<ref name="pmid21345403">{{cite journal | vauthors = Broussard CS, Rasmussen SA, Reefhuis J, Friedman JM, Jann MW, Riehle-Colarusso T, Honein MA | title = Maternal treatment with opioid analgesics and risk for birth defects | journal = American Journal of Obstetrics and Gynecology | volume = 204 | issue = 4 | pages = 314.e1–314.11 | date = April 2011 | pmid = 21345403 | doi = 10.1016/j.ajog.2010.12.039 | doi-access = free }}</ref> Symptoms of hydrocodone [[drug overdose|overdose]] include narrowed or widened pupils; slow, shallow, or stopped breathing; slowed or stopped heartbeat; cold, clammy, or blue skin; excessive sleepiness; loss of consciousness; seizures; or death.<ref name="MedlinePlus" /> Hydrocodone can be habit forming, causing physical and psychological dependence. Its abuse liability is similar to morphine and less than oxycodone.<ref name="pmid22992943">{{cite journal | vauthors = Wightman R, Perrone J, Portelli I, Nelson L | title = Likeability and abuse liability of commonly prescribed opioids | journal = Journal of Medical Toxicology | volume = 8 | issue = 4 | pages = 335–340 | date = December 2012 | pmid = 22992943 | pmc = 3550270 | doi = 10.1007/s13181-012-0263-x }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)